Acorda postpones IPO

Acorda Therapeutics (Hawthorne, N.Y.) postponed its IPO citing market conditions. The company is hoping to raise $57.6-$67.2 million through the sale 4.8 million shares at $12-$14. Spokesperson Tierne...